Investing Profile

Ken Sawyer

VCInvestorAngelFounder
Founder and Managing Director at Saints Capital
saintscapital.comUnited States
Photo of Ken Sawyer, Managing Director at Saints Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Saints Capital Managing Director
$250K - $100.0M
$10.0M
16
$27.4M
CompanyStageDateRound SizeTotal Raised
Direct Flow Medical
Series CApr 2016$31M
$98M
Co-investors: Jeani Delagardelle (New Leaf Venture Partners), Renee Compton Ryan (Johnson & Johnson Innovation), Annette Bianchi (VantagePoint Capital Partners)
Siftery
SeedFeb 2016$4M
$4M
Co-investors: Jeremy Philips (Spark Capital), Chris Scoggins (SignalFire), Sam Lessin (Slow Ventures), Tod Sacerdoti (Flex Capital), Jonah Goodhart (WGI Group), Patrick McKenna (Comeback Capital), Kevin Hartz (A* Capital (A Star Capital)), Mitch Kitamura (DNX Ventures), Michael Lazerow (Lazerow Ventures), Peter Kellner (Richmond Global Ventures), Charlie Songhurst, Russ Fradin, Mark Gerson, Jay Weintraub, Joanna Rees, Ron Hirson, Eric Stein, Evangelos Simoudis, Jeremy Lizt, Adam D'Angelo, Joe Zawadzki, Kim Perell, Brian O'Kelley, Tien Tzuo, Warren Jenson, Travis May
Fixt
SeedJan 2016$800K
$1.4M
Co-investors: Jonathan Weiner (Oak HC/FT), Joe Callanan (Blu Venture Investors), Alexander Bogusky (Batshit Crazy Ventures)
Acsis
Series AApr 2015$250K
$250K
Gilt Groupe
Series FFeb 2015$50M
$270M
Co-investors: Randy Glein (DFJ), Anton Levy (General Atlantic), Dana Stalder (Matrix), Henry Fertik (Strategic Beta)
OrSense
Series HFeb 2015
Series HApr 2014
Debt FinancingJan 2014
Vidyo
Series EJul 2014$20M
Series DApr 2013$17M
$130M
Co-investors: Avery More (Menlo Ventures), Douglas Carlisle
Laureate Pharma
Debt FinancingOct 2010$20M
$20M
We provide liquidity for founders and investors for their private shares in great companies -usually mature enough to have meaningful revenue traction
Pre-revenue companies or shares in companies where the investors and founders are not supportive of a secondary transaction